[go: up one dir, main page]

FI20115135A0 - Anti-inflammatory action of microfibrillated cellulose - Google Patents

Anti-inflammatory action of microfibrillated cellulose

Info

Publication number
FI20115135A0
FI20115135A0 FI20115135A FI20115135A FI20115135A0 FI 20115135 A0 FI20115135 A0 FI 20115135A0 FI 20115135 A FI20115135 A FI 20115135A FI 20115135 A FI20115135 A FI 20115135A FI 20115135 A0 FI20115135 A0 FI 20115135A0
Authority
FI
Finland
Prior art keywords
microfibrillated cellulose
inflammatory action
inflammatory
action
microfibrillated
Prior art date
Application number
FI20115135A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20115135A7 (en
FI20115135L (en
FI126259B (en
Inventor
Kaisa Herranen
Mia Lohman
Original Assignee
Upm Kymmene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43629806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20115135(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upm Kymmene Corp filed Critical Upm Kymmene Corp
Priority to FI20115135A priority Critical patent/FI126259B/en
Publication of FI20115135A0 publication Critical patent/FI20115135A0/en
Priority to PCT/FI2012/050129 priority patent/WO2012107648A1/en
Priority to JP2013552997A priority patent/JP6386226B2/en
Priority to ES12716475.4T priority patent/ES2661582T3/en
Priority to DK12716475.4T priority patent/DK2672950T3/en
Priority to US13/984,831 priority patent/US9018189B2/en
Priority to EP12716475.4A priority patent/EP2672950B1/en
Priority to NO12716475A priority patent/NO2672950T3/no
Publication of FI20115135A7 publication Critical patent/FI20115135A7/en
Publication of FI20115135L publication Critical patent/FI20115135L/en
Publication of FI126259B publication Critical patent/FI126259B/en
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Polymers & Plastics (AREA)

Abstract

The invention relates to use of microfibrillated cellulose as an anti-inflammatory agent for treatment of skin disorders.
FI20115135A 2011-02-11 2011-02-11 Microfibrillated cellulose for use in the treatment of atopic dermatitis and psoriasis FI126259B (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI20115135A FI126259B (en) 2011-02-11 2011-02-11 Microfibrillated cellulose for use in the treatment of atopic dermatitis and psoriasis
NO12716475A NO2672950T3 (en) 2011-02-11 2012-02-10
ES12716475.4T ES2661582T3 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose
JP2013552997A JP6386226B2 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrous cellulose
PCT/FI2012/050129 WO2012107648A1 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose
DK12716475.4T DK2672950T3 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose
US13/984,831 US9018189B2 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose
EP12716475.4A EP2672950B1 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20115135A FI126259B (en) 2011-02-11 2011-02-11 Microfibrillated cellulose for use in the treatment of atopic dermatitis and psoriasis

Publications (4)

Publication Number Publication Date
FI20115135A0 true FI20115135A0 (en) 2011-02-11
FI20115135A7 FI20115135A7 (en) 2012-08-12
FI20115135L FI20115135L (en) 2012-08-12
FI126259B FI126259B (en) 2016-09-15

Family

ID=43629806

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20115135A FI126259B (en) 2011-02-11 2011-02-11 Microfibrillated cellulose for use in the treatment of atopic dermatitis and psoriasis

Country Status (8)

Country Link
US (1) US9018189B2 (en)
EP (1) EP2672950B1 (en)
JP (1) JP6386226B2 (en)
DK (1) DK2672950T3 (en)
ES (1) ES2661582T3 (en)
FI (1) FI126259B (en)
NO (1) NO2672950T3 (en)
WO (1) WO2012107648A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI126513B (en) * 2011-01-20 2017-01-13 Upm Kymmene Corp Method for improving strength and retention and paper product
US20140134218A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Rinse-off skin care compositions containing cellulosic materials
US9370478B2 (en) 2012-11-09 2016-06-21 Johnson & Johnson Consumer Inc. Skin care compositions containing cotton and citrus-derived materials
US20140134217A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Leave-on compositions containing cellulose materials
FI126109B (en) 2013-02-22 2016-06-30 Upm Kymmene Corp Nanofibrillar polysaccharide for use in inhibiting and controlling lace and scar formation
FR3016296B1 (en) * 2014-01-14 2021-06-25 Feeligreen DEVICE FOR ELECTROSTIMULATION AND / OR IONTOPHORESIS
FI129421B (en) * 2014-03-12 2022-02-15 Maelkki Yrjoe Preparation and use of nanocellulose and its precursors
FI125758B (en) 2014-12-22 2016-02-15 Upm Kymmene Corp Process for reducing the viscosity of nanofibrillar cellulose hydrogel
FI129934B (en) 2015-02-13 2022-11-15 Upm Kymmene Corp Suture thread, method for producing suture thread and use thereof
EP3228329B1 (en) * 2016-04-06 2022-06-08 UPM-Kymmene Corporation A method for preparing a medical product comprising nanofibrillar cellulose and a medical product
CA3075983C (en) 2016-09-30 2023-09-19 Novaflux, Inc. Compositions for cleaning and decontamination
EP3775133B1 (en) 2018-04-03 2024-10-09 Novaflux, Inc. Cleaning composition with superabsorbent polymer
US20210299157A1 (en) * 2018-08-06 2021-09-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cellulose-based topical formulations
EP4041180A1 (en) 2019-10-03 2022-08-17 Novaflux Inc. Oral cavity cleaning composition, method, and apparatus
US12064495B2 (en) 2019-10-03 2024-08-20 Protegera, Inc. Oral cavity cleaning composition, method, and apparatus
ES2999324T3 (en) * 2019-10-31 2025-02-25 Upm Kymmene Corp Medical product and method for preparing thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378381A (en) 1980-10-31 1983-03-29 International Telephone And Telegraph Corporation Suspensions containing microfibrillated cellulose
JPS6239507A (en) * 1985-08-13 1987-02-20 Daicel Chem Ind Ltd Cosmetic for keeping skin in good state
DE4328871A1 (en) 1993-08-27 1995-03-02 Beiersdorf Ag Means against sensitive, hyper-reactive skin conditions, atopic dermatitis, pruritus, psoriasis prurigo, photodermatoses and ichthyosis
FR2730252B1 (en) * 1995-02-08 1997-04-18 Generale Sucriere Sa MICROFIBRILLED CELLULOSE AND ITS PROCESS FOR OBTAINING IT FROM PULP OF PLANTS WITH PRIMARY WALLS, IN PARTICULAR FROM PULP OF SUGAR BEET.
FR2744632B1 (en) 1996-02-13 1998-03-27 Oreal USE OF AN AQUEOUS SUSPENSION OF NATURALLY ORIGINAL MICROFIBRILLES FOR THE PREPARATION OF COSMETIC OR DERMATOLOGICAL COMPOSITIONS, COSMETIC OR DERMATOLOGICAL COMPOSITIONS AND APPLICATIONS
JPH09275424A (en) 1996-04-04 1997-10-21 Matsushita Electric Ind Co Ltd Transmission device
US6231657B1 (en) * 1996-07-15 2001-05-15 Rhodia Chimie Supplementation of cellulose nanofibrils with carboxycellulose with low degree of substitution
FR2769836B1 (en) 1997-10-21 2000-03-10 Rhodia Chimie Sa USE OF ESSENTIALLY AMORPHOUS CELLULOSE NANOFIBRILLES ASSOCIATED WITH AT LEAST ONE ORGANIC POLYHYDROXYL COMPOUND IN COSMETIC FORMULATIONS
FR2822679A1 (en) 2001-03-30 2002-10-04 Oreal COSMETIC COMPOSITION COMPRISING A MIXTURE OF FIBERS
JP4961772B2 (en) * 2005-03-01 2012-06-27 Ｊｎｃ株式会社 Compound selected from sulfated cellulose and its salt, and therapeutic agent for dermatitis
US8951551B2 (en) * 2005-08-31 2015-02-10 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
US20100254961A1 (en) 2007-09-05 2010-10-07 Taiyokagaku Co., Ltd. Water-soluble electrospun sheet
AU2008324033B2 (en) * 2007-11-05 2014-01-09 Humanitarian Scientific Llc Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias

Also Published As

Publication number Publication date
ES2661582T3 (en) 2018-04-02
JP2014505093A (en) 2014-02-27
FI20115135A7 (en) 2012-08-12
US20140045785A1 (en) 2014-02-13
JP6386226B2 (en) 2018-09-05
US9018189B2 (en) 2015-04-28
EP2672950B1 (en) 2017-12-13
FI20115135L (en) 2012-08-12
WO2012107648A1 (en) 2012-08-16
EP2672950A1 (en) 2013-12-18
DK2672950T3 (en) 2018-02-12
FI126259B (en) 2016-09-15
NO2672950T3 (en) 2018-05-12

Similar Documents

Publication Publication Date Title
FI20115135A0 (en) Anti-inflammatory action of microfibrillated cellulose
MX373103B (en) CYCLOPROPYLAMINES AS INHIBITORS OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1).
UA108101C2 (en) N3-substituted N1-sulfonyl-5-fluoropyrimidinone derivatives
UA117958C2 (en) HINOXALINE DERIVATIVES USEFUL AS FGFR KINAS MODULATORS
TR201816379T4 (en) DNA-PK inhibitors.
EA201691070A1 (en) NEW TRICYCLIC CONNECTIONS AS ANTICATIVE AGENTS
CR20130410A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE TRK
BR112015020389A2 (en) carbazole compounds useful as bromodomain inhibitors
EA201591728A1 (en) HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION
EA201300730A1 (en) Derivatives indazolyltriazole
GT201400034A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE QUINASE C-KIT
EA033811B1 (en) STABLE ANTI-CONSERVID MYDRIATIC AND ANTI-INFLAMMATORY INJECTION SOLUTIONS
UY33883A (en) NEW HETEROCYCLIC DERIVATIVES
EA201491817A1 (en) THERAPEUTIC APPLICATION OF PRODUCTS FROM THE GRAPE OF GRAPE CHARDONNEY
BR112016006388A2 (en) selective phosphatidylinositol 3-kinase gamma inhibitor
EA201490423A1 (en) METHODS AND COMPOSITIONS RELATED TO p62 FOR TREATMENT AND PREVENTION OF CANCER
EA201691032A1 (en) IZHOCHROMEN DERIVATIVES AS PHOSFOINOSYTID-3-KINAZ INHIBITORS
BR112015001697A2 (en) clomazone formulations
IN2015DN01151A (en)
BR112014028042A2 (en) nampt inhibitors
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
BR112019021867A2 (en) PHENYL-2-HYDROXY-ACETYLAMINE-2-METHYL-PHENY COMPOUNDS
CO7101239A2 (en) Compositions derived from chitosan
UA106889C2 (en) N1-ACYL-5-FLORPYRIMIDINONE DERIVATIVES
UY35747A (en) SUBSTITUTED DERIVATIVES OF PHENYLALANINE

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 126259

Country of ref document: FI

Kind code of ref document: B